Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome

NCT02741362 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Primary Investigator no longer with institution

Conditions

Systemic Lupus Erythematosus
Rheumatoid Arthritis
Sharp's Syndrome

Interventions

OTHER: Intravenous injection of Stromal Vascular Fraction Cells (SVF) containing ADSCs
OTHER: Lipoaspiration

Sponsor

Arkansas Heart Hospital